Swine flu fears boost drug giants

Swine flu, a new strain of influenza, has so far left more than a hundred dead. But in one sector, the illness could have huge benefits.  

 

Pharmaceutical companies profit grows as a yeast, and the interest in such companies as "Roche" or "GlaxoSmithKline" shares is rising and rising.